Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Immunogenicity of 10μg/0.5ml Recombinant Hepatitis B Vaccines(Saccharomyces Cerevisiae) in the Healthy Neonates

NCT02764671 is registered in ClinicalTrials.gov with Shenzhen Kangtai Biological Products Co., LTD as lead sponsor.

NCT NCT02764671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02764671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Immunogenicity of 10μg/0.5ml Recombinant Hepatitis B Vaccines(Saccharomyces Cerevisiae) in the Healthy Neonates
Lead sponsor
Shenzhen Kangtai Biological Products Co., LTD
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2015
Completion date
September 30, 2020
Enrollment
5,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

digestive system diseases, hepatitis, hepatitis b, liver diseases